Unité de Fabrication des Médicaments S.A (BVMT: UMED)
Tunisia
· Delayed Price · Currency is TND
7.09
-0.03 (-0.42%)
At close: Sep 12, 2024
UMED Revenue
In the year 2023, Unité de Fabrication des Médicaments S.A had annual revenue of 136.00M TND with 41.14% growth. Unité de Fabrication des Médicaments S.A had revenue of 74.75M in the half year ending December 31, 2023, with 70.49% growth.
Revenue
136.00M
Revenue Growth
+41.14%
P/S Ratio
1.67
Revenue / Employee
237.77K
Employees
572
Market Cap
226.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 136.00M | 39.64M | 41.14% |
Dec 31, 2022 | 96.36M | 11.85M | 14.02% |
Dec 31, 2021 | 84.51M | -6.53M | -7.18% |
Dec 31, 2020 | 91.04M | -16.16M | -15.07% |
Dec 31, 2019 | 107.21M | 20.12M | 23.10% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition